March 29, 2019
Mayo Clinic in the News Weekly Highlights for March 29, 2019
By Emily Blahnik 
Reuters, Biogen scraps two Alzheimer drug trials, wipes $18 billion from market value by Julie Steenhuysen — Biogen Inc and partner Eisai Co Ltd are ending two late-stage trials of their experimental Alzheimer’s disease drug aducanumab, a major setback in the quest to find a treatment for the mind-wasting disease and a blow to Biogen, […]
View full entry
Tags: AliveCor, alzheimer's disease, anal cancer, artificial Intelligence, Biogen, blood donation, Blood Donor Program, caffeine, cognitive decline, dementia, depression, Derrick Rose
March 28, 2019
ALS patient helps develop program to use facial muscles to move wheelchair
By Karl Oestreich 
Florida Times-Union by Matt Soergel When artist Sandra Murphy-Pak could no longer move her arms to paint, she began using the toes of her right foot, dipping them in paint and applying the paint to the canvas. Her condition has worsened, and six years after noticing the first symptoms of ALS, she can no longer […]
View full entry
Tags: A.L.S., Dr. Bjorn Oskarsson, Florida Times-Union, Sandra Murphy-Pak